Astrazeneca AZN
NYSE AZN
$163.70 +3.53 (+2.20%)
As of: Sep 14, 2026 · 3:06 PM EDT

Astrazeneca (AZN) Revenue Growth (1y) (2010 - 2026)

Analysis

Astrazeneca (AZN) Revenue Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Asml Holding 618.78 Bn 602.80 Bn 5.90 Bn 14.28%
2 Hsbc Holdings 362.62 Bn 362.62 Bn - -
3 General Electric 329.79 Bn 320.45 Bn 6.95 Bn 21.10%
4 Astrazeneca 253.78 Bn 248.49 Bn 12.86 Bn 6.47%
5 Citigroup 228.38 Bn -2,073.93 Bn 24.75 Bn -
6 Bhp 216.07 Bn 197.52 Bn - -
7 Rio Tinto 203.71 Bn 199.33 Bn - -
8 Diageo 197.09 Bn 195.06 Bn - -
9 Unilever 139.31 Bn 132.28 Bn - 3.53%
10 Hdfc Bank 117.84 Bn 80.69 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.47%
Mar 31, 2026 12.56%
Dec 31, 2025 10.10%
Sep 30, 2025 12.39%
Jun 30, 2025 11.71%
Mar 31, 2025 6.97%
Dec 31, 2024 -56.64%
Sep 30, 2024 22.58%
Jun 30, 2024 18.86%
Mar 31, 2024 19.57%
Dec 31, 2023 189.69%
Sep 30, 2023 0.33%
Jun 30, 2023 2.37%
Mar 31, 2023 -7.23%
Dec 31, 2022 -2.53%
Sep 30, 2022 12.74%
Jun 30, 2022 32.13%
Mar 31, 2022 56.95%
Dec 31, 2021 64.00%
Sep 30, 2021 49.40%